Job description
The Principal Research Scientist - Medicinal Chemist at Elanco will play a crucial role in small molecule drug discovery, focusing on the design and synthesis of innovative medicines for animal health. This position involves collaboration with a global team of scientists and the application of advanced technologies like AI/ML and DNA-Encoded Libraries. The role is based in Indianapolis and offers a hybrid work environment. The successful candidate will significantly impact the discovery portfolio and contribute to the future of the research team.
Requirements
- PhD in Medicinal Chemistry, Organic Chemistry, or a related scientific discipline.
- A minimum of 8-10 years of relevant industry experience in medicinal chemistry within a pharmaceutical, biotechnology, or animal health research environment.
- Demonstrated expertise in modern medicinal chemistry, including the design and multi-step synthesis of complex small molecules.
- Strong understanding of Structure-Activity Relationships (SAR), pharmacology, and ADME/PK principles.
- Proven ability to autonomously manage scientific initiatives within a cross-functional team and manage external collaborations with CROs.
Responsibilities
- Drive the design and optimization of novel small molecules by leveraging advanced synthetic strategies and integrating biological, pharmacological, and ADME/PK data to guide structure–activity relationship (SAR) campaigns.
- Lead medicinal chemistry initiatives within multidisciplinary teams, partnering with Biology, Pharmacology, DMPK, Toxicology, and Computational Sciences to drive the strategic progression of drug discovery programs.
- Serve as a key medicinal chemistry figure on multidisciplinary project teams, collaborating with partners in Biology, Pharmacology, DMPK, Toxicology, and Computational Sciences to strategically advance discovery programs.
- Direct synthetic chemistry efforts with external Contract Research Organizations (CROs) and internal partners, ensuring the efficient execution of project goals and timelines.
- Leverage cutting-edge drug discovery technologies, including DNA-Encoded Libraries (DEL), computational chemistry, and AI/ML-enabled tools, to accelerate hit identification and lead optimization.
- Drive IP strategy by exploring novel chemical space and developing patent applications in collaboration with the IP team.
- Promote scientific excellence and data integrity while providing mentorship and technical guidance to junior scientists, fostering a culture of innovation and collaboration.
Benefits
- Employees at Elanco are often offered competitive compensation with annual bonus and equity eligibility, retirement plans (including a U.S. 401(k)), and comprehensive health coverage—medical, dental, vision, company-paid life and disability—and even pet insurance. Time-off and flexibility typically include generous PTO, U.S. mid-year and year-end paid shutdown weeks, parental leave, and flexible/remote work options. Employees also benefit from strong development programs (onboarding, course libraries, mentorship, nine ERGs, and tiered leadership programs) that support both professional growth and community involvement.
H-1B filing history
Public USCIS petition and DOL LCA counts · latest USCIS FY2026, LCA FY2026
Combined across 2 filing entities: Elanco Us Inc, Elanco Animal Health Inc
As of Aug 23, 2026
Initial approvals
4
FY2026
Approval rate
100.0%
FY2026
LCA certified
12
FY2026
Entry-level share
0.0%
FY2026
Initial approvals YoY
+3%
Trend
LCA certified YoY
-25%
Trend
Initial approvals by fiscal year
Approval rate by fiscal year
Continuing vs initial approvals
LCA certified positions by quarter
LCA certified positions by fiscal year
Based on public USCIS and DOL filings; not a sponsorship guarantee.
Is this posting expired or inaccurate?
